Scott Bluni serves as co-chair of the firm’s Intellectual Property Group. His practice involves all aspects of intellectual property law, including portfolio management, licensing, product clearance, litigation and due diligence, with particular emphasis in medical devices and life science patent matters. Prior to joining Bingham, Scott was vice president and cardiovascular chief patent counsel at a major global medical device company.
Scott is a former patent examiner at the United States Patent and Trademark Office, where he had responsibility for applications relating to metal matrix composites and other materials science applications.